CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $152.72M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 10.09: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
The statements on file don't all cover the same year: income statement FY2025, balance sheet FY2024, cash-flow statement FY2024. Each figure below is labelled with the year it comes from.
Financials view
Market Capitalization
113.08MGBP152.72M · vs all stocks (USD)
Trailing P/E
24.40xvs Medical Devices peers
Revenue (TTM)
51.56MGBP69.64M · vs all stocks (USD)
Profit Margin
4.12%vs Medical Devices peers
Beta
0.5130xvs all stocks
52-Week Change
-10.27%vs all stocks
Market Capitalization
113.08MGBP152.72M · vs all stocks (USD)
Enterprise Value
99.55MGBP134.44M · vs all stocks (USD)
Trailing P/E
24.40xvs Medical Devices peers
Forward P/E
14.18xvs Medical Devices peers
Price to Sales (TTM)
2.17xvs Medical Devices peers
Price to Book (MRQ)
1.64xvs Medical Devices peers
Enterprise to Revenue
1.93xvs Medical Devices peers
Enterprise to EBITDA
9.80xvs Medical Devices peers
Profit Margin
4.12%vs Medical Devices peers
Operating Margin
12.88%vs Medical Devices peers
Return on Assets (TTM)
5.36%vs Medical Devices peers
Return on Equity (TTM)
3.53%vs Medical Devices peers
Revenue (TTM)
51.56MGBP69.64M · vs all stocks (USD)
Revenue per Share (TTM)
0.1150GBPUpdated Jul 29, 2026Quarterly Revenue Growth
5.40%vs Medical Devices peers
Gross Profit (TTM)
26.48MGBP35.76M · vs all stocks (USD)
EBITDA (TTM)
12.64MGBP17.07M · vs all stocks (USD)
Net Income (TTM)
2.12MGBP2.87M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-95.70%vs Medical Devices peers
Operating Cash Flow (TTM)
9.71MGBP13.11M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
6.67MGBP9.00M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
885.00KGBPFY2024 · Dec 31, 2024EPS (Basic)
0.0047GBPFY2025 · Dec 31, 2025EPS (Diluted)
0.0047GBPFY2025 · Dec 31, 2025Basic Shares Outstanding
448.33MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
448.33MSharesFY2025 · Dec 31, 2025Operating Cash Flow
7.25MGBPFY2024 · Dec 31, 2024Free Cash Flow
5.09MGBPFY2024 · Dec 31, 2024Cash & Cash Equivalents (End of Period)
14.30MGBPFY2024 · Dec 31, 2024Starting Profit (CF Statement)
6.26MGBPFY2024 · Dec 31, 2024Stock-based Compensation
0.00GBPFY2024 · Dec 31, 2024Other Non-cash Items
341.00KGBPFY2024 · Dec 31, 2024Change in Accounts Receivable (CF)
-122.00KGBPFY2024 · Dec 31, 2024Change in Other Assets/Liabilities
765.00KGBPFY2024 · Dec 31, 2024Capital Expenditures
-2.15MGBPFY2024 · Dec 31, 2024Net Intangibles (CF)
-510.00KGBPFY2024 · Dec 31, 2024Sale of Investments
0.00GBPFY2024 · Dec 31, 2024Net Investing Cash Flow
-2.15MGBPFY2024 · Dec 31, 2024Long-term Debt Issuance
0.00GBPFY2024 · Dec 31, 2024Long-term Debt Payments
-3.00MGBPFY2024 · Dec 31, 2024Net Financing Cash Flow
-3.00MGBPFY2024 · Dec 31, 2024Shares Outstanding
433.83MSharesUpdated Jul 29, 2026Float Shares
351.18MSharesUpdated Jul 29, 2026% Held by Insiders
1.18%vs all stocks
% Held by Institutions
73.89%vs all stocks
Total Cash (MRQ)
13.69MGBP18.48M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0320GBPUpdated Jul 29, 2026Total Debt (MRQ)
1.39MGBP1.87M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0197xvs Medical Devices peers
Current Ratio (MRQ)
4.16xvs Medical Devices peers
Book Value per Share (MRQ)
0.1590GBPUpdated Jul 29, 2026Total Assets
81.75MGBP110.40M · vs all stocks (USD)
Total Current Assets
28.55MGBPFY2024 · Dec 31, 2024Total Liabilities
8.53MGBPFY2024 · Dec 31, 2024Total Non-current Assets
53.19MGBPFY2024 · Dec 31, 2024Total Non-current Liabilities
2.10MGBPFY2024 · Dec 31, 2024Total Current Liabilities
6.44MGBPFY2024 · Dec 31, 2024Cash
13.01MGBPFY2024 · Dec 31, 2024Cash & Cash Equivalents
13.01MGBPFY2024 · Dec 31, 2024Accounts Receivable
5.84MGBPFY2024 · Dec 31, 2024Inventory
7.39MGBPFY2024 · Dec 31, 2024Accounts Payable
900.00KGBPFY2024 · Dec 31, 2024Short-term Debt
420.00KGBPFY2024 · Dec 31, 2024Long-term Debt
898.00KGBPFY2024 · Dec 31, 2024Common Stock (Book)
4.54MGBPFY2024 · Dec 31, 2024Retained Earnings
55.00MGBPFY2024 · Dec 31, 2024Total Shareholders' Equity
73.21MGBP98.88M · vs all stocks (USD)
52-Week Low
21.80GBXUpdated Jul 29, 202652-Week High
32.00GBXUpdated Jul 29, 202652-Week Change
-10.27%vs all stocks
Beta
0.5130xvs all stocks
50-Day MA
26.20GBXUpdated Jul 29, 2026200-Day MA
25.60GBXUpdated Jul 29, 2026Avg 10-Day Volume
195.54KSharesUpdated Jul 29, 2026Avg 30-Day Volume
187.50KSharesUpdated Jul 29, 2026Diluted EPS (TTM)
0.0047GBPUpdated Jul 29, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 10.09: safe zoneNotable
Altman Z-Score: 10.09
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $152.72M, lower than 95% of all stocks globallySignificant
Market cap (USD): 152,721,887.36Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
HLB Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Yungjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
S Biomedics Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Chill Brands Group Plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
Enlivex Therapeutics Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Graphy Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sensorion SA
Tier 1ProductionApproval-Gated PipelineRuleRisk
Mycenax Biotech Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Journey Medical Corp
Tier 1ProductionApproval-Gated PipelineRule
Alector Inc.
Tier 1ProductionApproval-Gated PipelineRule